Thymostimulinum
TFX contains thymic factor X, which is an extract of calf thymus containing proteins and polypeptides. The active substance of the medicine has an effect similar to that of substances secreted by the human thymus, i.e. it stimulates the immune system. TFX increases the number of white blood cells - T lymphocytes, increases the body's resistance, inhibits autoaggressive processes, and reduces the adverse effects of cytostatic (anti-cancer) and immunosuppressive drugs on the hematopoietic system. The use of TFX is recommended in disease syndromes with primary and secondary immunodeficiency; as supportive treatment to stimulate the immune system in the basic therapy of cancer; in chronic, aggressive hepatitis; in some brain and spinal cord diseases; in secondary hemopoietic disorders (blood cell production), also post-drug or after X-ray irradiation.
Before starting treatment with TFX, discuss it with your doctor or pharmacist. When using TFX, be particularly careful:
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, and about the medicines you plan to take. TFX may increase the effect of some pituitary hormones (somatotropin, luteinizing hormone) and estrogens, and reduce the effect of adrenal cortex hormones, progesterone, and androgens on the lymphatic system and bone marrow.
In pregnancy, during breastfeeding, or if you suspect you are pregnant, or if you plan to become pregnant, consult your doctor or pharmacist before using this medicine.
There are insufficient data on the use of thymic factor X in pregnant women. Animal studies have shown toxic effects on the fetus. The potential risk to humans is not known.
There are no clinical data on the use of TFX during breastfeeding, therefore, it is not recommended to use the medicine during breastfeeding.
TFX has no effect on the ability to drive and use machines.
The medicine contains tiomersal as a preservative and may cause allergic reactions. Inform your doctor if you have had any known allergic reactions.
Always use this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. Method of administration: Subcutaneous or intramuscular injection. Usually, 10 to 20 mg is used daily for 30 days, and then 20 to 30 mg weekly. Further use of the medicine, treatment time, and dosage depend on the achieved effect and the results of relevant tests. Method of preparation: The solution for injection should be prepared immediately before use. To do this, following the principles of aseptic procedure, dissolve the contents of the vial using the solvent contained in the ampoule. Using a syringe, take 1 ml of solvent from the ampoule and introduce it into the vial with the lyophilized substance. Mix the contents of the vial to obtain a homogeneous solution. The prepared solution is ready for subcutaneous or intramuscular injection.
The risk of overdose of TFX is unlikely and limited, as thymic peptides are sensitive to the action of certain proteins (enzymes) that reduce the concentration of the medicine in the blood and do not have a direct stimulating or inhibiting effect on immune functions.
Do not use a double dose to make up for a missed dose. If you miss a dose of TFX, use it as soon as possible, taking into account that longer than one-day breaks in administration may reduce the effectiveness of therapy.
Sudden discontinuation of TFX reduces its effectiveness, depending on the duration of treatment, and does not pose any other adverse consequences. If you have any further questions about the use of this medicine, ask your doctor.
Like all medicines, TFX can cause side effects, although not everybody gets them. Possible side effects after using TFX include: General disorders and administration site conditions. No general adverse reactions. Local reaction: redness and slight pain may occur at the injection site. Immune system disorders. Skin allergic reactions may occur: redness, itching, skin rash. If the above symptoms occur, discontinue the use of the medicine for 1-2 days.
If you experience any side effects, or any other side effects not mentioned in the leaflet, tell your doctor or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products {current address, phone and fax number of the Department} e-mail: ndl@urpl.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 25°C. Store in a place out of sight and reach of children. Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the given month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
10 vials with powder 10 mg + 10 ampoules with solvent 1 ml, 50 vials with powder 10 mg + 50 ampoules with solvent 1 ml. Vials and ampoules made of colorless glass in a cardboard box.
Marketing authorization holder: TFX PHARMA Sp. z o. o., ul. Muchoborska 6, 54-424 Wrocław. Manufacturer: Przedsiębiorstwo Farmaceutyczne Jelfa S.A., Ul. Wincentego Pola 21, 58-500 Jelenia Góra.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.